UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

The Lancet (British edition), 2000-07, Vol.356 (9227), p.385-390

2000

Volltextzugriff (PDF)

Etanercept as Monotherapy in Patients with Psoriasis

The New England journal of medicine, 2003-11, Vol.349 (21), p.2014-2022

2003

Volltextzugriff (PDF)

Diagnosis and treatment of psoriatic arthritis

Journal of the American Academy of Dermatology, 2005, Vol.52 (1), p.1-19

2005

Volltextzugriff (PDF)

Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database

Journal of the American Academy of Dermatology, 2006-03, Vol.54 (3), p.S92-S100

2006

Volltextzugriff (PDF)

Treatment of moderate to severe plaque psoriasis with concomitant efalizumab and narrow-band ultraviolet B phototherapy

Journal of drugs in dermatology, 2008-10, Vol.7 (10), p.947

2008

Volltextzugriff (PDF)

A randomized trial of etanercept as monotherapy for psoriasis

Archives of dermatology (1960), 2003-12, Vol.139 (12), p.1627

2003

Volltextzugriff (PDF)

The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives

American health & drug benefits, 2016-12, Vol.9 (9), p.504-513

2016

Volltextzugriff (PDF)

Open label trial of alefacept in palmoplantar pustular psoriasis

The Journal of dermatological treatment, 2008, Vol.19 (2), p.97-100

2008

Volltextzugriff (PDF)

Assessment of Natural Sunlight Protection Provided by 10 High-SPF Broad-Spectrum Sunscreens and Sun-Protective Fabrics

Current problems in dermatology, 2021, Vol.55, p.157

2021

Volltextzugriff (PDF)

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

The Journal of clinical investigation, 1999-05, Vol.103 (9), p.1243-1252

1999

Volltextzugriff (PDF)

Disseminated granuloma annulare resolved with the T-cell modulator efalizumab

Archives of dermatology (1960), 2004-10, Vol.140 (10), p.1287

Goffe, Bernard S

2004

Volltextzugriff (PDF)

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes

Journal of drugs in dermatology, 2008-03, Vol.7 (3), p.245

2008

Volltextzugriff (PDF)

An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy

Clinical therapeutics, 2005-12, Vol.27 (12), p.1912-1921

2005

Volltextzugriff (PDF)

Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

International journal of dermatology, 2006-05, Vol.45 (5), p.605-614

2006

Volltextzugriff (PDF)

Clobetasol propionate emulsion formulation foam 0.05%: Review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents

Journal of the American Academy of Dermatology, 2008-09, Vol.59 (3), p.448-454.e1

2008

Volltextzugriff (PDF)

Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis

Journal of the American Academy of Dermatology, 1996-03, Vol.34 (3), p.429-433

1996

Volltextzugriff (PDF)

CD4 + T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study

Journal of the American Academy of Dermatology, 2003-11, Vol.49 (5), p.816-825

2003

Volltextzugriff (PDF)

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis

Journal of the American Academy of Dermatology, 1998-10, Vol.39 (4), p.590-596

1998

Volltextzugriff (PDF)

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks

Journal of the American Academy of Dermatology, 2003-05, Vol.48 (5), p.760-767

2003

Volltextzugriff (PDF)

Safety of etanercept in an integrated multi-study database of patients with psoriasis

Journal of the American Academy of Dermatology, 2004-03, Vol.50 (3), p.P158-P158

2004

Volltextzugriff (PDF)

The safety of efalizumab in patients with moderate to severe plaque psoriasis: summary of clinical trial experience

Journal of the American Academy of Dermatology, 2004-03, Vol.50 (3), p.P157-P157

2004

Volltextzugriff (PDF)

Etanercept in patients with psoriatic arthritis: sustained improvement in skin and joint disease

Journal of the American Academy of Dermatology, 2004-03, Vol.50 (3), p.P55-P55

2004

Volltextzugriff (PDF)

Etanercept monotherapy in patients with psoriasis : A summary of safety, based on an integrated multistudy database: The evolution of dermatologic therapeutics: Current uses of etanercept in psoriasis and other dermatoses

Journal of the American Academy of Dermatology, 2006, Vol.54 (3)

2006

Volltextzugriff (PDF)

An integrated analysis of thirteen trials summarizing thelong-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy

Clinical therapeutics, 2005-12, Vol.27 (12), p.1912-1921

2005

Volltextzugriff (PDF)

Pharmacology and therapeutics: Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

International journal of dermatology, 2006-05, Vol.45 (5), p.605-614

2006

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(36)
Französisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

Etanercept as Monotherapy in Patients with Psoriasis

Diagnosis and treatment of psoriatic arthritis

Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database

Treatment of moderate to severe plaque psoriasis with concomitant efalizumab and narrow-band ultraviolet B phototherapy

A randomized trial of etanercept as monotherapy for psoriasis

The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives

Open label trial of alefacept in palmoplantar pustular psoriasis

Assessment of Natural Sunlight Protection Provided by 10 High-SPF Broad-Spectrum Sunscreens and Sun-Protective Fabrics

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

Disseminated granuloma annulare resolved with the T-cell modulator efalizumab

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes

An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy

Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

Clobetasol propionate emulsion formulation foam 0.05%: Review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents

Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis

CD4 + T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks

Safety of etanercept in an integrated multi-study database of patients with psoriasis

The safety of efalizumab in patients with moderate to severe plaque psoriasis: summary of clinical trial experience

Etanercept in patients with psoriatic arthritis: sustained improvement in skin and joint disease

Etanercept monotherapy in patients with psoriasis : A summary of safety, based on an integrated multistudy database: The evolution of dermatologic therapeutics: Current uses of etanercept in psoriasis and other dermatoses

An integrated analysis of thirteen trials summarizing thelong-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy

Pharmacology and therapeutics: Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

Suchergebnisse filtern